$IBIO I jumped on this stock in Jan because of the biotech. Fast Pharming, Glycaneering, and VLPs are extremely powerful technology backed by a litany of research. Technicals don’t guide my decision on the stock. CDMO outlook, BioInk, Rituximab and iBios tech do.
  • 15
15 Likes